PREDQ.US Predictive Technology Group, Inc.
- Market cap
- USD 3.00K
- P/E
- -
- P/B
- 0.00x
- ROE
- -123.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Mar 2021.
Is PREDQ.US undervalued?
Graham numberThe Graham number of Predictive Technology Group, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Predictive Technology Group, Inc. fundamental analysis
No fundamental analysis for Predictive Technology Group, Inc. yet.
Predictive Technology Group, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Predictive Technology Group, Inc.
Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women exper…
Full company profilePredictive Technology Group, Inc. financial statements
2021 annualized: Fiscal year 2021 is not finished. Income statement and cash flow are annualized from 3 quarters up to Mar 31, 2021, the balance sheet is the latest quarter. Figures change when the annual report is published.
Predictive Technology Group, Inc. annual financial statements
| Item | 2006 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | - | - | 2.59M | 16.6M | 43.5M | 43.5M | 24.4M | 21.4M |
| Gross Profit | - | - | 1.83M | 12.7M | 27.2M | 27.2M | 3.86M | 9.12M |
| Operating Income | -11.9K | -28.2K | -2.39M | -12.3M | -19.9M | -19.9M | -46.7M | -14.2M |
| EBITDA | -11.9K | -28.2K | -1.40M | -7.82M | -10.6M | -11.5M | -85.2M | -20.4M |
| Net Income | -12.1K | -28.3K | -6.17M | -6.07M | -15.3M | -85.8M | -85.9M | -40.1M |
| EPS | -0.08 | -0.15 | -0.04 | -0.03 | -0.06 | -0.32 | -0.30 | -0.13 |
| Balance Sheet | ||||||||
| Total Assets | 16.9K | 8.08K | 39.9M | 104M | 144M | 83.8M | 83.8M | 67.0M |
| Total Liabilities | - | - | 100K | 22.6M | 31.0M | 28.9M | 28.9M | 35.1M |
| Shareholders' Equity | 16.9K | 8.08K | 39.9M | 81.5M | 113M | 55.3M | 55.3M | 32.3M |
| Cash & Short-term Investments | 16.8K | 8.08K | 4.51K | 968K | 1.62M | 331K | 331K | 152K |
| Total Debt | - | - | - | - | 2.42M | 7.84M | 7.84M | 13.4M |
| Cash Flow | ||||||||
| Operating Cash Flow | -9.17K | -8.75K | -141K | -289K | 3.49M | 3.49M | -13.1M | -8.45M |
| Capital Expenditure | 0.00 | 0.00 | 325K | 2.06M | 2.71M | 2.71M | 1.03M | 483K |
| Free Cash Flow | -9.17K | -8.75K | -467K | -1.14M | 786K | 786K | -14.1M | -8.77M |
| Ratios | ||||||||
| ROE | -71.4% | -350.9% | -15.5% | -7.4% | -13.6% | -155.1% | -155.4% | -123.9% |
| ROA | -71.4% | -350.9% | -15.5% | -5.8% | -10.7% | -102.3% | -102.5% | -59.8% |
| Net Profit Margin | - | - | -238.8% | -36.5% | -35.2% | -197.2% | -351.4% | -187.2% |
| Debt to Equity | - | - | - | - | 0.02x | 0.14x | 0.14x | 0.42x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Predictive Technology Group, Inc. dividends
Predictive Technology Group, Inc. has not paid dividends in the last 7 fiscal years.
Last stock split: 1:10 on Jul 29, 2010.
Who owns Predictive Technology Group, Inc.
Ownership data of Predictive Technology Group, Inc. is not available yet.
Predictive Technology Group, Inc. company profile
- Company name
- Predictive Technology Group, Inc.
- Ticker
- PREDQ.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 62
- Fiscal year end
- June
- Address
- 2735 Parleys Way, Salt Lake City, UT, United States, 84109
- Phone
- 801 584 3600
- Website
- predtechgroup.com
About Predictive Technology Group, Inc.
Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditions; and regenerative medicine products, including AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte for use in regenerative medicine applications. It has a collaboration agreement with Atrin Pharmaceuticals LLC to develop molecular diagnostic tools to facilitate enhanced selection of cancer patients. The company was formerly known as Global Enterprises Group, Inc. and changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group, Inc. was founded in 2005 and is headquartered in Salt Lake City, Utah. On November 9, 2023, Predictive Technology Group, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Utah. On January 12, 2024, the voluntary petition of Predictive Technology Group, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on November 9, 2023.
Predictive Technology Group, Inc. management
3- Mr. Bradley C. RobinsonCEO, President & Director · born 1969
- Dr. Michael Dey Ph.D.CEO of Predictive Therapeutics & Director · born 1952
- Dr. Bruce D. Forrest B.S., M.B.A., M.D., Ph.D.Chief Development Officer · born 1963